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The COVID-19 crisis has not only deeply affected those with SARS-CoV-2 infections, and their 
families, but it has also had an unprecedented global economic impact. The travel and tourism 
sectors have been particularly hard hit, with aircraft grounded, hotels closed, and travel 
restrictions and quarantines introduced around the world. The United Nations’ World Tourism 
Organization predicts there will be declines of 58% to 78% in international tourist arrivals this 
year.
1
  
 
There are increasing numbers of COVID-19 cases in many countries, including Australia, 
Brazil, France, Spain, and Japan. Whilst some of the apparent surge may be a result of increased 
testing, there is a concern of a second wave. In the Spanish flu pandemic of 1918, which killed 
50-100 million people, it was the second wave that produced the greatest number of deaths.
2
 
 
As a defence against a second wave of COVID-19, it is critically important that measures are 
put in place to prevent the importation of new cases from countries with a high incidence of 
COVID-19. Some countries, like the United Kingdom, require inbound travellers to self-isolate 
when they arrive from such countries or territories. For example, currently, travellers returning 
to the UK from Spain, which generates almost 12% of its GDP from tourism and is the most 
popular destination in the world for British tourists, are subject to compulsory self-isolation for 
14 days, alongside any travellers showing signs of COVID-19. Other countries have a stricter 
quarantine, with travellers being required to self-isolate in specific quarantine centres, and others 
have closed their borders to arrivals. 
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Screening travellers for COVID-19 at airports is an attractive option that could prevent imported 
infections, and may reduce the need to enforce quarantine on travellers. Infrared thermal image 
scanners have been used previously during epidemics, but modelling studies indicate that, even 
under best-case assumptions, thermal screening will miss more than half of infected people.
3
 
Many cases are fundamentally undetectable through these scanners because infected individuals 
may be presymptomatic or do not have a fever at the time of scanning. There remains a need for 
a sensitive, rapid, non-invasive means of screening large numbers of asymptomatic people, both 
at departure and on arrival into ports. Previous work with bio-detection dogs suggests that 
highly-trained dogs may offer a viable solution to COVID-19 detection. 
 
Detection of disease-associated odours by dogs 
There is evidence that respiratory infections cause the release of specific odours. The analysis of 
volatiles liberated in breath, urine, faeces and sweat has shown that microbial infections are 
associated with the production of specific volatile organic compounds (VOCs), and that the ratio 
of these VOCs differs depending on the infectious microorganisms.
4
 This area of research has 
led to interest in using volatiles as biomarkers of infectious diseases, such as cholera. 
 
Other, more recent work by the authors, demonstrated that asymptomatic malaria infection also 
causes changes in VOCs, which vary throughout the infection.
5
 Further work by the same team 
demonstrated the use of trained dogs in identifying malaria parasites in asymptomatic children.
6
 
The dogs were trained using odour samples collected on socks worn by confirmed positive 
asymptomatic or negative children in The Gambia. The dogs were then trained to distinguish 
between the odours of socks worn by infected and uninfected children. Once training was 
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completed, a second set of specimens was used in a double blinded study to determine the 
specificity and sensitivity of detection. The study demonstrated that dogs could identify malaria 
with a degree of sensitivity and specificity broadly in line with the World Health Organization’s 
criteria for the procurement of rapid diagnostic tests.
6
 The findings of this research are highly 
relevant for COVID-19 detection, since a high proportion of COVID-19 cases are thought to be 
asymptomatic or present with mild symptoms. Further, it is likely that some SARS-CoV-2 
infections are transmitted by asymptomatic infected individuals, and the lack of symptoms may 
render them undetectable by other screening measures. 
 
Previous research on the odours accompanying viral infections has provided evidence that 
distinct VOCs are produced by infections with different viruses. For example, patterns of VOCs 
produced in response to infection in B lymphoblastoid cells were found to be unique for H9N2, 
H6N2, and H1N1 viruses.
7
 There is also evidence that dogs can detect and learn the smell of 
virus-associated volatiles in real time, with sensitivities of up to 96% and specificity of up to 
98%.
8
 
 
Could trained dogs be used for the detection of COVID-19? 
Dogs have extremely sensitive olfactory systems, capable of detecting concentrations as low as 
1.5 parts per trillion, and there is growing interest in their use for medical purposes. Several 
studies have now shown that medical detection dogs can be trained to detect different cancers 
and bacterial infections. The SARS-CoV-2 pandemic has encouraged several groups to 
investigate the use of detection dogs in identifying COVID-19 through changes in body odour. 
In Germany, preliminary findings indicate that trained detection dogs were able to discriminate 
UN
CO
RR
EC
TE
D 
MA
NU
SC
RI
PT
6 
 
6 
 
between samples of SARS-CoV-2 infected and non-infected individuals with an average 
diagnostic sensitivity of 83%.
9
  
 
With a view to a more practical future application, a team in France trained detection dogs in the 
identification of COVID-19 positive individuals from axillary sweat. Although the number of 
samples used was relatively small, the authors concluded that there is a very high degree of 
evidence that the armpit sweat odour of COVID-19 positive individuals is different from that of 
SARS-CoV-2 uninfected individuals, and that dogs can successfully detect infection through 
these differences.
10
  
 
Whilst these results are encouraging, there are significant limitations with these studies. For 
example, only seven participants were recruited in the German study and there was a lack of 
relevant SARS-CoV-2 uninfected individuals to control for confounding factors. It is possible 
that with such a small number of independent samples the dogs remember the odour of the 
individuals rather than a distinct odour associated with SARS-CoV-2 infection. It should also be 
noted that the study required the donation of saliva samples and tracheobronchial secretion 
samples, and that the positive group was comprised of individuals showing clinical symptoms, 
which would limit the application of this proof-of-concept study to clinical settings. The 
limitations of both these studies highlight the need for a scientific study with a robust design and 
sufficient sample size to evaluate the diagnostic sensitivity and specificity of COVID detection 
dogs in reliably identifying asymptomatic carriers of SARS-CoV-2.  
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In March this year, we commenced a prospective three-phase study in the UK involving 
collection of body and breath odour samples from more than three hundred asymptomatic and 
mildly symptomatic participants. Phase 1 is a proof-of-principle study to demonstrate that 
medical detection dogs can be trained to identify asymptomatic or mild symptomatic infections 
with SARS-CoV-2 with high sensitivity and specificity. Phase 2 is an assessment of the 
capability of the trained dogs to detect people with asymptomatic or mildly symptomatic SARS-
CoV-2 infection. This important step will move the research team closer to deployment of dogs, 
and will require the sensitivity and specificity of the dogs to be assessed at COVID-19 test 
centres where they can sniff individuals waiting to donate swab samples for formal diagnosis. 
Phase 3 will deploy trained dogs at UK ports of entry to screen travellers for SARS-CoV-2 
infection. Further complementary work is being done to identify which VOCs are associated 
with an infection with SARS-CoV-2, which may lead to the development of sensors for 
detection of people with a COVID-19.  
 
If bio-detection dogs prove to be effective in the detection of asymptomatic or mildly 
symptomatic individuals, there is enormous potential for them to be used at key entry points, 
such as airports and sea ports, to support efforts to screen departing or incoming passengers, 
which is crucial for ensuring safer, and fully operational, global travel in the future, and for any 
elimination strategies. Each trained dog can screen up to 250 people in an hour and they could 
be stationed before entering the terminal building, at the security checkpoint for outbound 
passengers and staff, and at border control for inbound passengers. Positive individuals and their 
contacts could then isolate to prevent the spread of infection to others. This will be of significant 
benefit to the economy and the control of the pandemic, as it could eliminate the need to keep 
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borders closed or to require the quarantine of all travellers. Dogs could also be used in localised 
outbreaks, and at other venues where large numbers of people need to be screened rapidly, for 
example, at train stations, stadiums and workplaces. If we are able to demonstrate that dogs can 
detect COVID-19 with high accuracy, we propose the development of a preparedness and 
response platform using pre-trained pathogen detection dogs that could be trained and deployed 
rapidly during the early stages of an outbreak, and be operational within weeks. Disease 
detection dogs could help improve health security at border entry points by reducing the 
likelihood of re-introduction of SARS-CoV-2, and potentially other viruses, into at-risk 
countries. 
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